Isomorphic Labs

“generational talent has generational prices in today... he's going to pull together a team like's never been seen since the dawn of mankind in artificial intelligence.”

“here the value capture is not replace labor. It's actually make science discoveries... when you create the $200 billion drug, you want to get 10% of that on a royalty basis.”

“Isomorphic Labs... in talks to raise at $40-50B after about $10B from Thrive”

“IsoDDE more than doubles AlphaFold 3's accuracy on a hard protein-ligand benchmark”

“In May 2026, Thrive led a $2.1B Series B to scale IsoDDE, Isomorphic's drug design engine, toward the clinic.”

“Isomorphic 'is in early talks to raise new funds at a valuation of at least $40 billion.'”

“First, there seems to be a Google/Demis Hassabis premium on Isomorphic.”

“Wall Street is scratching its head over Iambic Therapeutics, an AI biotech that plans to go public this week. Either it's the bargain of a lifetime or the private markets are wildly overvaluing one of its top comps, Alphabet-backed Isomorphic Labs.”

“Isomorphic Labs, a five-year-old London startup that applies AI to drug discovery, is reportedly in early talks to raise a new round at a valuation of at least $40 billion, potentially as high as $50 billion.”

“Biohub, the Department of Energy, the National Institutes of Health, Google DeepMind, Isomorphic Labs, Meta and a collection of scientific organizations are collaborating to create and standardize data for what Biohub calls a 'universal virtual cell.'”

“Demis Hassabis was stepping back from his role as the CEO of DeepMind to become the division's Chair and Chief Scientist at Alphabet, letting him focus more on Google's AI biotech wing Isomorphic Labs.”

“A lot of times folks think about Chai and Isomorphic in the same neighborhood. Isomorphic is developing drugs. You guys are enabling the existing industry to develop drugs more efficiently.”

“Isomorphic Labs' $2 billion round — the second largest in biotech history — accounted for nearly 20% of the total [biopharma VC] that quarter.”

“When isomorphic's round was oversubscribed 8-10x, the capital that didn't get in created enormous investor pressure and interest that cascaded directly into Chai Discovery ($400M at $3.8B) and then further into Latent Labs in London. This is a repeatable, exploitable pattern.”

“I think of the prominent AI leaders, I think Demis does a pretty good job of actually translating the technology into more quantifiable and tangible ways for like your every person.”

“Momentum shows up in named pharma partnerships (Novartis, Lilly, Johnson & Johnson), a mix of partnered and wholly owned programs, and the company's push to move internal assets toward the clinic.”

“Isomorphic Labs raised $2.1B for 'AI-driven drug discovery and biological data analysis.'”

“Isomorphic Labs, a spinout from Google, has raised more than $2 billion to fund AI-based drug discovery.”

“Isomorphic Labs is in preclinical stage on multiple programs across immune disorders and cancer.”

“Raised $2.1B in Series B funding to scale its AI-driven drug discovery platform backed by Alphabet and Thrive Capital.”

“Isomorphic Labs brings in $2.1 billion.”

“Isomorphic Labs, which is our latest spin out... is to build adjacent technologies in more biochemistry and chemistry space that can actually design the compounds automatically.”

“At Isomorphic Labs, which we spun out from DeepMind after we did AlphaFold 2”